随着门内透管大动脉置换,永久心脏起器植入的预测因素

Karol Quelal Analuisa1, Namrata Arya2, Teodora Donisan1

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

概括

预先存在的双纤膜阻塞,更深的隔膜植入和新的捆绑分支阻塞预测在门内透管大动脉置换 (ViV-TAVR) 后需要永久心脏起器植入 (PPI). 大动脉反可能会降低PPI风险.